Attention Deficit Hyperactivity Disorder (ADHD) News and Research

RSS

Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral).

Specific orofacial characteristics can lead to accurate diagnosis of fetal alcohol spectrum disorders

Fetal alcohol spectrum disorders (FASD) is an umbrella term that describes the range of effects that can occur in a person whose mother drank alcohol while pregnant. Each year, FASD affect an estimated 40,000 infants in the United States—more than spina bifida, Down syndrome, and muscular dystrophy combined.

22 Sep 2010

Researchers explain how nerve cells transmit electrical signals

Billions of brain cells are communicating at any given moment. Like an organic supercomputer they keep everything going, from breathing to solving riddles, and "programming errors" can lead to serious conditions such as schizophrenia, Parkinson's disease and attention-deficit hyperactivity disorder.

22 Sep 2010

Shire to host panel discussion for ADHD

Shire plc, the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of National Attention Deficit Hyperactivity Disorder Awareness Week to host "Fact or Fiction ADHD in America, a Capitol Hill Forum."

17 Sep 2010

Research on signaling pathways may help to design therapy for neurodevelopmental disorders

Researchers at the Center for Neuroscience Research at Children's National Medical Center have discovered that the two major types of signaling pathways activated during brain cell development-the epidermal growth factor receptor pathway and the Notch pathway-operate together to determine how many and which types of brain cells are created during growth and repair in developing and adult brains.

17 Sep 2010

Research suggests methodical approaches to control severe aggression among children with ADHD

Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine, and colleagues, found that almost half of children with attention-deficit/hyperactivity disorder whose aggressive behaviors had not been effectively controlled during routine outpatient care could achieve near absence of aggressive, explosive behavior when implementing "first-line" stimulant treatments for ADHD tailored to individual needs, along with behavioral therapy.

16 Sep 2010

NAMI launches new, interactive, online resource center to support children, adults with ADHD

The National Alliance on Mental Illness has launched a new, interactive, online resource center to support children and adults living with attention-deficit hyperactivity disorder.

16 Sep 2010

MRI brain scans can accurately predict young person's age

Using MRI technology and mathematical analysis, researchers at Oregon Health & Science University and Washington University in St. Louis are now able to accurately predict a young person's age simply by studying their brain scans. The research, which will likely have several clinical applications, including assessment and diagnosis, is published in the current edition of the journal Science.

15 Sep 2010

ADHD medication improves childhood cancer survivors: Research

A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital investigators.

14 Sep 2010

Nation's four leading ADHD organizations seek to end persistent myths about ADHD

Four national organizations – ADHD Coaches Organization; Attention Deficit Disorder Association; ADDitude magazine; and Children and Adults with Attention-Deficit/Hyperactivity Disorder – are issuing a joint call to the public to assist children, adults, and families who are affected by ADHD.

9 Sep 2010

Methylphenidate facilitates recovery from drug addiction

A brain-scanning study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, conducted with collaborators from Stony Brook University, reveals that an oral dose of methylphenidate, commonly known as Ritalin, improves impaired brain function and enhances cognitive performance in people who are addicted to cocaine.

7 Sep 2010

FDA approves Atomoxetine HCl capsules for ADHD

Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD).

2 Sep 2010

Anxiety in school is seasonal and age dependent: Pediatric psychiatrists

With summer fading, anxiety is on the rise for some students anticipating the return of school. But it isn't just the first days of classes that can provoke angst -- anxiety in school is seasonal and age dependent, say pediatric psychiatrists.

2 Sep 2010

USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.

2 Sep 2010

Children, teens need good health before the start of new school year, says medical director

With the back to school shopping season in full swing, it is also important to arm area children and teens with other tools they need to have a good school year- like medical exams. These are critical to good health and should take place before or shortly after the start of the new school year, and include a routine doctor's exam to confirm that all immunizations are up-to-date, a dental check-up, and a vision exam.

30 Aug 2010

Latest achievements in brain research and treatment for mental disorders

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

30 Aug 2010

23rd ECNP Press conference on impact of circadian rhythms on human brain

All humans are synchronised to the rhythmic light-dark changes that occur on a daily basis. Rhythms in physiological and biochemical processes and behavioural patterns persist in the absence of all external 24-hour signals from the physical environment, with a period that is close to 24 hours

30 Aug 2010

Simple medical exams recommended for school-age children

Many children and teens are enjoying the remaining days of their summer vacation, but are they truly prepared for what lies ahead? With a few simple medical exams, Virginia's school-age children will be armed with the tools they need to enjoy a healthy school year. The exams we are referring to are given in a doctor's and/or dentist's office, and should take place before or shortly after the start of the new school year, and include a routine doctor's exam to confirm that all immunizations are up-to-date, a dental exam and a vision exam.

27 Aug 2010

KemPharm broadens protection for LAT prodrug technology platform for ADHD with second patent

KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.

27 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

26 Aug 2010

Worldwide conference to discuss increase in autism, help restore health

The Centers for Disease Control and Prevention (CDC) recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.

26 Aug 2010

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Further Reading

Specific orofacial characteristics can lead to accurate diagnosis of fetal alcohol spectrum disorders

Researchers explain how nerve cells transmit electrical signals

Shire to host panel discussion for ADHD

Research on signaling pathways may help to design therapy for neurodevelopmental disorders

Research suggests methodical approaches to control severe aggression among children with ADHD

NAMI launches new, interactive, online resource center to support children, adults with ADHD

MRI brain scans can accurately predict young person's age

ADHD medication improves childhood cancer survivors: Research

Nation's four leading ADHD organizations seek to end persistent myths about ADHD

Methylphenidate facilitates recovery from drug addiction

FDA approves Atomoxetine HCl capsules for ADHD

Anxiety in school is seasonal and age dependent: Pediatric psychiatrists

USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA

Children, teens need good health before the start of new school year, says medical director

Latest achievements in brain research and treatment for mental disorders

23rd ECNP Press conference on impact of circadian rhythms on human brain

Simple medical exams recommended for school-age children

KemPharm broadens protection for LAT prodrug technology platform for ADHD with second patent

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Worldwide conference to discuss increase in autism, help restore health

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News